In summary, patients presenting with a pre-existing procoagulant condition and increased Ang II levels, are more prone to develop severe coagulation disorders and thrombotic events upon SARS-CoV-2 infection, especially if accompanied by hyperglycemia as summarized in Figure 26. The gene discussed is AGT; the disease is blood coagulation disease.